- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.02. | Devyser Diagnostics AB: Devyser Diagnostics publishes year-end report for January to December 2023 | 220 | GlobeNewswire (Europe) | "Devyser is able to report strong sales growth and record high gross margins for the fourth quarter. During the quarter, Devyser continued to demonstrate the competitiveness of its products by winning... ► Artikel lesen | |
| 05.12.23 | DEVYSER DIAGNOSTICS AB: Devyser wins tender for non-invasive fetal RHD testing in Wales | 1 | Cision News | ||
| 09.11.23 | Devyser Diagnostics AB publishes quarterly report for July to September 2023 | 1 | Cision News | ||
| 23.08.23 | Devyser Diagnostics AB publishes quarterly report for the period April to June 2023 | 454 | PR Newswire | STOCKHOLM, Aug. 23, 2023 /PRNewswire/ -- "The second quarter of the year saw an improvement in EBIT compared with recent quarters, continued high gross margins, strong growth and an exclusive... ► Artikel lesen | |
| 17.07.23 | Devyser Diagnostics AB: Devyser's NGS products for monitoring of kidney and stem cell transplanted patients receive IVDR approvals | 425 | PR Newswire | STOCKHOLM, July 17, 2023 /PRNewswire/ -- Devyser's novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening and... ► Artikel lesen | |
| 30.06.23 | Devyser Diagnostics AB: Devyser has inaugurated its CLIA-certified laboratory and performed the first patient fetal RhD test | 400 | PR Newswire | STOCKHOLM, June 30, 2023 /PRNewswire/ -- Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory will offer clinical test services for hereditary diseases... ► Artikel lesen | |
| 29.06.23 | Devyser Diagnostics AB: Devyser Launches Two New Genetic Testing Solutions for Hereditary Cancer | 328 | PR Newswire | STOCKHOLM, June 29, 2023 /PRNewswire/ -- Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA PALB2. These kits offer efficient, targeted, and... ► Artikel lesen | |
| 11.05.23 | Devyser Diagnostics AB: Approval of Devyser's RHD product in Canada | 432 | PR Newswire | STOCKHOLM, May 11, 2023 /PRNewswire/ -- Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted regulatory approval in Canada. Devyser already has... ► Artikel lesen | |
| 09.05.23 | Devyser Diagnostics AB publishes quarterly report for the period January to March 2023 | 459 | PR Newswire | STOCKHOLM, May 9, 2023 /PRNewswire/ -- "The first quarter of the year saw continued strong growth, record gross margin and the launching of our first IVDR-approved product. After the end... ► Artikel lesen | |
| 08.05.23 | Devyser Diagnostics AB: Devyser's clinical laboratory receives CLIA certification | 686 | PR Newswire | STOCKHOLM, May 8, 2023 /PRNewswire/ -- Devyser is today announcing that the company's clinical testing laboratory in Roswell in Atlanta, Georgia, has received CLIA certification. This certification... ► Artikel lesen |
10 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 75,24 | +0,07 % | Medtronic Plc-Aktie läuft heute schlechter (75,3286 €) | Der Anteilsschein von Medtronic Plc notiert am Dienstag etwas leichter. Das Wertpapier kostete zuletzt 80,46 US-Dollar. Heute hat sich an der US-amerikanischen Börse der Anteilsschein von Medtronic... ► Artikel lesen | |
| HCA HEALTHCARE | 289,30 | 0,00 % | HCA Healthcare, Inc. Q1 Profit Increases, beats estimates | WASHINGTON (dpa-AFX) - HCA Healthcare, Inc. (HCA) released a profit for its first quarter that increased from the same period last year and beat the Street estimates.The company's earnings came... ► Artikel lesen | |
| AMEDISYS | 84,00 | -0,59 % | Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise | ||
| LANTHEUS | 70,18 | +12,58 % | Lantheus Holdings, Inc.: Lantheus Reports First Quarter 2024 Financial Results | First Quarter 2024 Worldwide revenue of $370.0 million, an increase of 23.0% from first quarter 2023 GAAP fully diluted net income per share of $1.87, compared to GAAP fully diluted net loss per... ► Artikel lesen | |
| ENVISTA | 18,500 | -3,14 % | Envista Holdings Corporation: Envista Reports First Quarter 2024 Results | BREA, Calif., May 1, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the first quarter of 2024.
For the quarter ended March 29, 2024, reported sales were... ► Artikel lesen | |
| CAREDX | 8,600 | +18,20 % | CareDx, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| GT BIOPHARMA | 3,180 | +1,92 % | GT Biopharma, Inc. - 8-K, Current Report | ||
| SYNEOS HEALTH | 40,000 | 0,00 % | Research and Markets: 2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report Featuring IQVIA, ICON, Parexel, Fortrea (formerly Labcorp), PPD/Thermo Fisher, and Syneos Health - ResearchAndMarkets.com | The "2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report" has been added to ResearchAndMarkets.com's offering.
The biopharmaceutical clinical development landscape... ► Artikel lesen | |
| CARMAT | 2,900 | -3,33 % | CARMAT: Availability of the 2023 Universal Registration Document | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| CHEMOMETEC | 39,720 | -0,10 % | Chemometec A/S: Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year | ANNOUNCEMENT NO. 261 Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year According to the preliminary figures, revenue in the third quarter... ► Artikel lesen | |
| HAMILTON THORNE | 0,915 | 0,00 % | Bloom Burton & Co. Inc.: Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference | Beverly, Massachusetts--(Newsfile Corp. - April 10, 2024) - Hamilton Thorne Ltd. (TSX: HTL) (OTC Pink: HTLZF), Hamilton Thorne Ltd. a leading provider of precision instruments, laboratory equipment... ► Artikel lesen | |
| POLAREAN IMAGING | 0,011 | -18,52 % | Polarean Imaging PLC - U.S. Patent granted for Xenon MRI | ||
| ARRAIL GROUP | 0,750 | +3,45 % | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | ||
| SIEMENS HEALTHINEERS | 51,20 | -1,73 % | EQS-DD: Siemens Healthineers AG: Dr. Bernhard Montag, Kauf von Siemens Healthineers Aktien für einen Betrag von EUR 98.817,91 abzüglich Steuern und Abgaben als automatische Wiederanlage von ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
26.04.2024 / 14:49... ► Artikel lesen | |
| FRESENIUS | 27,970 | 0,00 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius vor Quartalszahlen von 41 auf 40 Euro gesenkt und die Einstufung auf "Buy" belassen. Ein zunächst vorsichtiger... ► Artikel lesen |
DEVYSER DIAGNOSTICS AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 7,920 Euro und damit -4,35 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
